EP2461682A4 - Verfahren zur behandlung von autistischen erkrankungen und zusammensetzungen dafür - Google Patents

Verfahren zur behandlung von autistischen erkrankungen und zusammensetzungen dafür

Info

Publication number
EP2461682A4
EP2461682A4 EP09848121A EP09848121A EP2461682A4 EP 2461682 A4 EP2461682 A4 EP 2461682A4 EP 09848121 A EP09848121 A EP 09848121A EP 09848121 A EP09848121 A EP 09848121A EP 2461682 A4 EP2461682 A4 EP 2461682A4
Authority
EP
European Patent Office
Prior art keywords
compositions
methods
same
autism spectrum
spectrum disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09848121A
Other languages
English (en)
French (fr)
Other versions
EP2461682A1 (de
Inventor
Theoharis C Theoharides
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Theta Biomedical Consulting and Development Co Inc
Original Assignee
Theta Biomedical Consulting and Development Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theta Biomedical Consulting and Development Co Inc filed Critical Theta Biomedical Consulting and Development Co Inc
Priority to EP13180466.8A priority Critical patent/EP2710893A1/de
Publication of EP2461682A1 publication Critical patent/EP2461682A1/de
Publication of EP2461682A4 publication Critical patent/EP2461682A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
EP09848121A 2009-08-03 2009-08-03 Verfahren zur behandlung von autistischen erkrankungen und zusammensetzungen dafür Withdrawn EP2461682A4 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP13180466.8A EP2710893A1 (de) 2009-08-03 2009-08-03 Verfahren zur Behandlung von autistischen Erkrankungen und Zusammensetzungen dafür

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2009/052577 WO2011016799A1 (en) 2009-08-03 2009-08-03 Methods of treating autism spectrum disorders and compositions for same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP13180466.8A Division EP2710893A1 (de) 2009-08-03 2009-08-03 Verfahren zur Behandlung von autistischen Erkrankungen und Zusammensetzungen dafür

Publications (2)

Publication Number Publication Date
EP2461682A1 EP2461682A1 (de) 2012-06-13
EP2461682A4 true EP2461682A4 (de) 2013-03-06

Family

ID=43544551

Family Applications (2)

Application Number Title Priority Date Filing Date
EP09848121A Withdrawn EP2461682A4 (de) 2009-08-03 2009-08-03 Verfahren zur behandlung von autistischen erkrankungen und zusammensetzungen dafür
EP13180466.8A Withdrawn EP2710893A1 (de) 2009-08-03 2009-08-03 Verfahren zur Behandlung von autistischen Erkrankungen und Zusammensetzungen dafür

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP13180466.8A Withdrawn EP2710893A1 (de) 2009-08-03 2009-08-03 Verfahren zur Behandlung von autistischen Erkrankungen und Zusammensetzungen dafür

Country Status (2)

Country Link
EP (2) EP2461682A4 (de)
WO (1) WO2011016799A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103221043B (zh) * 2010-08-05 2016-04-06 卡斯西部储备大学 用于治疗神经元连接发育障碍的erk抑制剂
CN111983098B (zh) * 2020-08-28 2023-03-21 中山大学附属第七医院(深圳) 一种肠道微生物代谢物在制备自闭症诊断试剂盒中的用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080160007A1 (en) * 2007-01-03 2008-07-03 Michael Powell Diagnosis and treatment of cancer related to human dormancy
WO2010062681A2 (en) * 2008-10-30 2010-06-03 University Of South Florida Luteolin and diosmin/diosmetin as novel stat3 inhibitors for treating autism

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821259A (en) * 1991-11-12 1998-10-13 Theoharides; Theoharis C. H3 -receptor agonists as therapeutic agents
US7906153B2 (en) 1998-04-08 2011-03-15 Theta Biomedical Consulting & Development Co., Inc. Anti-inflammatory compositions for treating multiple sclerosis
US7115278B2 (en) * 1998-04-08 2006-10-03 Theoharis C Theoharides Proteoglycan compositions for the treatment of cardiovascular inflammatory diseases
GB0008326D0 (en) * 2000-04-06 2000-05-24 Shs International Ltd Diagnosis and treatment of autism and related disorders
US6696074B2 (en) 2000-12-04 2004-02-24 Tei Biosciences, Inc. Processing fetal or neo-natal tissue to produce a scaffold for tissue engineering
US20060179492A1 (en) * 2002-12-09 2006-08-10 The Regents Of The University Of California Method of inhibiting neural transmission mediated by serotonin-2a and enhancing sensorimotor gating
WO2005092324A1 (en) * 2004-03-19 2005-10-06 The Trustees Of Columbia University In The City Of New York Ginkgolide compounds, compositions, extracts, and uses thereof
US7745487B2 (en) * 2006-07-17 2010-06-29 Quercegen Pharma Llc Method for enhancing physical performance or immune system recovery from intense physical excercise with quercetin-containing compositions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080160007A1 (en) * 2007-01-03 2008-07-03 Michael Powell Diagnosis and treatment of cancer related to human dormancy
WO2010062681A2 (en) * 2008-10-30 2010-06-03 University Of South Florida Luteolin and diosmin/diosmetin as novel stat3 inhibitors for treating autism

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: ".Autism Reversed Carlee #1 .", 27 December 2008 (2008-12-27), XP002687625, Retrieved from the Internet <URL:http://www.youtube.com/watch?v=K-r7G20h_lw> [retrieved on 20121120] *
ANONYMOUS: "Autism LutiMax Reversed 2 short .", 29 December 2008 (2008-12-29), XP002687624, Retrieved from the Internet <URL:http://www.youtube.com/watch?v=iauhfJ00avQ> [retrieved on 20121120] *
ANONYMOUS: "LutiMax - Luteolin", 27 April 2009 (2009-04-27), XP002687628, Retrieved from the Internet <URL:http://web.archive.org/web/20090427094229/http://www.lutimax.com/> [retrieved on 20121121] *
ANONYMOUS: "LutiMax - Luteolin", 9 May 2008 (2008-05-09), XP002687627, Retrieved from the Internet <URL:http://web.archive.org/web/20080509054008/http://lutimax.com/> [retrieved on 20121121] *
ELLIS SUSAN: "Help for Autism with a supplement", 14 February 2009 (2009-02-14), XP002687626, Retrieved from the Internet <URL:http://www.kylestreehouse.org/forums.aspx?g=posts&t=448> [retrieved on 20121120] *
LI X ET AL: "Elevated immune response in the brain of autistic patients", JOURNAL OF NEUROIMMUNOLOGY, vol. 207, no. 1-2, 15 February 2009 (2009-02-15), ELSEVIER SCIENCE PUBLISHERS BV, XX, pages 111 - 116, XP025994094, ISSN: 0165-5728, [retrieved on 20090120], DOI: 10.1016/J.JNEUROIM.2008.12.002 *
S. AKHONDZADEH ET AL: "Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial", JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, vol. 29, no. 2, 1 April 2004 (2004-04-01), pages 145 - 150, XP055045091, ISSN: 0269-4727, DOI: 10.1111/j.1365-2710.2004.00546.x *
S. E. P. SMITH ET AL: "Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6", JOURNAL OF NEUROSCIENCE, vol. 27, no. 40, 3 October 2007 (2007-10-03), pages 10695 - 10702, XP055044947, ISSN: 0270-6474, DOI: 10.1523/JNEUROSCI.2178-07.2007 *
S. JANG ET AL: "Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 105, no. 21, 1 January 2008 (2008-01-01), pages 7534 - 7539, XP055044949, ISSN: 0027-8424, DOI: 10.1073/pnas.0802865105 *
S.-S GUDARZI ET AL: "Cyproheptadine in treatment of autism", EUROPEAN PSYCHIATRY, vol. 17, no. 4, 1 July 2002 (2002-07-01), pages 230 - 231, XP055045087, ISSN: 0924-9338, DOI: 10.1016/S0924-9338(02)00662-4 *
See also references of WO2011016799A1 *

Also Published As

Publication number Publication date
WO2011016799A1 (en) 2011-02-10
EP2710893A1 (de) 2014-03-26
EP2461682A1 (de) 2012-06-13

Similar Documents

Publication Publication Date Title
EP2473054A4 (de) Zusammensetzungen und verfahren zur behandlung von leukämie
EP2293800A4 (de) Zusammensetzungen und verfahren zur behandlung von ohrerkrankungen
EP2603202A4 (de) Zusammensetzungen und verfahren zur behandlung von tauopathien
EP2544688A4 (de) Verfahren und zusammensetzungen zur behandlung des angelman-syndroms und von störungen aus dem autismusspektrum
IL207752A0 (en) Methods of treating inflammation
HK1166305A1 (zh) 用於治療炎症的組合物及方法
EP2331564A4 (de) Verfahren zur behandlung von entzündungen
SI2300614T1 (sl) Metode in sestavki za zdravljenje mitohondrijskih motenj
ZA201006988B (en) Method and compositions for treatment of cancer
EP2773212A4 (de) Verfahren und zusammensetzungen zur behandlung von autismus
EP2504428A4 (de) Verfahren und zusammensetzungen zur behandlung oxalat-vermittelter leiden
IL214455A0 (en) Methods and compositions for treatment of neovascularization
EP2429584A4 (de) Behandlungsverfahren und -zusammensetzungen
ZA201106577B (en) Compounds and compositions for cognition-enhancement,methods of making,and methods of treating
ZA201203002B (en) Compositions and methods for treating inflammatory disorders
EP2558622A4 (de) Zusammensetzungen und verfahren zur identifikation von störungen aus dem autismusspektrum
EP2550361A4 (de) Zusammensetzungen und verfahren zur behandlung neurologischer störungen
EP2480579A4 (de) Verfahren zur behandlung von entzündungen
HK1167101A1 (en) Compositions and methods for treatment of multiple sclerosis
EP2490721A4 (de) Zusammensetzungen, behandlungsverfahren und diagnose autoimmun-vermittelter erkrankungen sowie verfahren zur herstellung solcher zusammensetzungen
EP2515652A4 (de) Zusammensetzungen und verfahren zur behandlung von vitiligo
EP2328402A4 (de) Verfahren und zusammensetzungen zur verlängerung der haltbarkeit einer frucht
PT2201950T (pt) Compostos e métodos para tratar doenças do espetro do autismo
EP2461682A4 (de) Verfahren zur behandlung von autistischen erkrankungen und zusammensetzungen dafür
EP2411020A4 (de) Zusammensetzungen und verfahren zur behandlung von blutungen

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20120228

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A01N 43/04 20060101AFI20121130BHEP

Ipc: A61P 25/28 20060101ALI20121130BHEP

Ipc: A61K 31/353 20060101ALI20121130BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20130201

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/353 20060101ALI20130125BHEP

Ipc: A01N 43/04 20060101AFI20130125BHEP

Ipc: A61P 25/28 20060101ALI20130125BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130903